Product Updates and Industry Developments

BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that the Company’s new Microwave Ablation System (MicroThermX^®) products were showcased at the Company’s exhibition booth at the 37th annual scientific meeting of the Society of Interventional Radiology (SIR), which was held March 24 to 29, 2012 in San Francisco. The SIR conference is the world’s largest and most comprehensive meeting for minimally more...

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that hyperthermia was featured at the annual meeting of the German Cancer more...

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today the ongoing success of the Company’s MicroThermX^® Microwave more...

BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize targeted heat therapy to treat cancer, today announced that the Company promoted the MicroThermX^® more...

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize targeted heat therapy to treat cancer, today announced the success of the Company's hyperthermia exhibit at the more...

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the MicroThermX^® Microwave Ablation System ( more...

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, announced that Grosshadern University Medical Center (Grosshadern), a premier medical center more...

BSD Medical Corporation (NASDAQ: BSDM) (the “Company” or “BSD”) is pleased to announce success of the MicroThermX^® Microwave Ablation System (MicroThermX^®) at the World Conference on Interventional Oncology (WCIO) held in New York City, June 9 to 12, 2011. The advantages of the MicroThermX^® system were the focus of two scientific presentations at the WCIO meeting.

BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that, due to recent sales and increased clinical utilization, BSD and the more...

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) today announced the successful delivery of its first lung cancer patient treatment with the MicroThermX^® Microwave Ablation System. The treatment was conducted by Damian E. Dupuy, M.D., at The Comprehensive Cancer Center at Rhode Island Hospital (Rhode Island Hospital) in Providence, Rhode Island. Dr.

BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) today announced initial patient treatments conducted at Beaumont Hospital in Royal Oak, Michigan. Beaumont is among the first in the nation to use BSD's innovative new MicroThermX^® Microwave Ablation System. BSD’s initial product launch was focused on placement of a select number of systems with pivotal, high-profile, interventional oncology centers and key opinion leaders.

BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD) today announced the successful treatment of four cancer patients at prestigious hospitals in Italy using BSD's innovative new MicroThermX^® Microwave Ablation System. The treatments were conducted within a four-day period and were attended by numerous key Italian physicians.